Ischemic optic neuropathy is infarction of the optic disk. The only constant symptom is painless vision loss. Diagnosis is clinical. Treatment is ineffective.

Two varieties of optic nerve infarction exist: nonarteritic and arteritic. The nonarteritic variant occurs more frequently, typically affecting people about 50 yr and older. Vision loss tends not to be as severe as in the arteritic variant, which typically affects an older group, typically about 70 yr and older.

Most ischemic optic neuropathy is unilateral. Bilateral, sequential cases occur in about 20%, but bilateral simultaneous involvement is uncommon. Bilateral involvement is much more common among arteritic than nonarteritic cases. Atherosclerotic narrowing of the posterior ciliary arteries may predispose to nonarteritic optic nerve infarction, particularly after a hypotensive episode. Any of the inflammatory arteritides, especially giant cell arteritis (see Vasculitis: Giant Cell Arteritis), can precipitate the arteritic form.

Acute ischemia causes nerve edema, which further worsens ischemia. A small optic cup to optic disk ratio is a risk factor for nonarteritic ischemic optic neuropathy but not for the arteritic variety. Usually, no medical condition is found as the apparent cause of the nonarteritic variety, although factors contributing to atherosclerosis (eg, diabetes, smoking, hypertension), obstructive sleep apnea, certain drugs (eg, amiodaroneSome Trade Names
CORDARONE
Click for Drug Monograph
, possibly phosphodiesterase-5 inhibitors), and hypercoagulable disorders are present in some patients and are thought to be risk factors. Vision loss on awakening leads investigators to suspect nocturnal hypotension as a potential cause of the nonarteritic variety.

Symptoms and Signs

Vision loss with both varieties is typically rapid (over minutes, hours, or days) and painless. Some patients notice the loss on awakening. Symptoms such as general malaise, muscle aches and pains, headaches over the temple, pain when combing hair, jaw claudication, and tenderness over the temporal artery may be present with temporal arteritis; however, such symptoms may not occur until after vision is lost. Visual acuity is reduced, and an afferent pupillary defect is present. The optic disk is swollen and elevated with loss of fine optic nerve vessels and often hemorrhages surrounding the optic disk. The optic disk is often pale in the arteritic variety and hyperemic in the nonarteritic variety. In both varieties, visual field examination often shows a defect in the inferior and central visual fields.

Diagnosis

• ESR and often C-reactive protein
• CT or MRI if vision loss is progressive

Diagnosis is based mainly on a clinical evaluation, but ancillary testing may be needed. Most important is to exclude the arteritic variety because the other eye is at risk if treatment is not started quickly. ESR is usually dramatically elevated in the arteritic variety and is normal in the nonarteritic variety. CBC, if done for other reasons, may show thrombocytosis. If giant cell arteritis is suspected, temporal artery biopsy should be done and C-reactive protein is a useful monitoring test. For isolated cases of progressive vision loss, CT or MRI should be done to rule out compressive lesions.

For nonarteritic ischemic optic neuropathy, additional testing may be indicated based on the suspected cause or risk factor. For example, if patients have excessive daytime sleepiness or snoring or are obese, polysomnography should be considered to diagnose obstructive sleep apnea. If patients have vision loss on awakening, 24h BP monitoring can be done.

Prognosis

There is no effective treatment, and most lost vision is not recovered; however, in the nonarteritic variety, up to 40% of patients spontaneously recover some useful vision.

Treatment

• Corticosteroids for the arteritic variety

The arteritic variety is treated with oral corticosteroids (prednisoneSome Trade Names
DELTASONE
Click for Drug Monograph
80 mg po once/day and tapered based on ESR) to protect the other eye. Treatment should not be delayed while awaiting biopsy results. Treatment of the nonarteritic variety with aspirinSome Trade Names
BUFFERIN
ECOTRIN
GENACOTE
Click for Drug Monograph
or corticosteroids has not been helpful. Risk factors are controlled. Low-vision aids (eg, magnifiers, large-print devices, talking watches) may be helpful in both types.

Pearls & Pitfalls Give systemic corticosteroids as soon as possible to patients who have sudden, painless loss of vision until giant cell arteritis is excluded.

Key Points

• Ischemic optic neuropathy is usually caused by giant cell arteritis or atherosclerosis.
• Sudden, painless loss of vision is the hallmark symptom.
• Exclude giant cell arteritis to decrease the risk of contralateral involvement.
• Prognosis tends to be poor.
• Give corticosteroids if giant cell arteritis is possible.

Last full review/revision September 2012 by James Garrity, MD

Content last modified November 2012